Healthcare -
Biotechnology - NASDAQ - US
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
KPTI - OPERATING EXPENSES
Operating Expenses KPTI - Karyopharm Therapeutics Inc.
259 M
LAST VALUE
-6.21%
2 YEAR CAGR
2.58%
5 YEAR CAGR
13.02%
10 YEAR CAGR